
Conference Coverage
18 days ago
AAOpt 2025: Fitting irregular corneasLatest Content

Shorts






Podcasts
Videos
Optometry Times Digital Edition




Continuing Medical Education
All News

The FDA acknowledged the primary efficacy end point was met but determined the data did not confirm the effectiveness of low-dose atropine in children, according to the company.

Andrew Rixon, OD, FAAO, gives an overview of one of his presentations at AAOpt's Academy 2025.

Fovea-sparing, multifocal, and bilateral lesions exhibited the fastest growth rates.


Karen Hoffman, OD, provides advice for eye care providers looking to build confidence in scleral lens fitting.

Cecelia Koetting, OD, FAAO, DIpABO, details her poster presentation at AAOpt's Academy 2025 meeting.

Harthan, OD, FAAO, FSLS, presented 2 posters on recent study results involving the lens at AAOpt's Academy 2025 meeting.

Eric Schmidt, OD, FAAO, details a poster presentation given during AAOpt's Academy 2025 meeting.

The trial evaluated the safety, efficacy, and tolerability of AURN001 in patients with corneal edema secondary to corneal endothelial dysfunction.

Cecelia Koetting, OD, FAAO, DipABO, emphasized that the field of regenerative medicine is continuously expanding, with new devices and approaches constantly emerging.

Brooke Messer, OD, FAAO, FSLS, and Tiffany Andrzejewski, OD, FAAO, discussed the pearls, pitfalls, and best practices of scleral lens fitting.

The FDA-approved topical cross-linking treatment aims to simplify keratoconus care while improving patient comfort, with availability expected in early 2026.

Locking in correct prescriptions is as easy as checking a box.

Catch up on the top stories in optometry during the week of October 13-October 17.











































































.png)


